You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 28, 2026

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
Nicolas F M Porta1, Robin H Steinhorn
1Children's Memorial Hospital and Northwestern University, Chicago, IL, United States.
Inhaled nitric oxide (NO) is a key treatment for persistent pulmonary hypertension of the newborn (PPHN). Research explores enhancing NO therapy and its use in other neonatal conditions and preterm infants.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: